Support      Login

Support      Login

FundamentalVR Announces Upcoming Endovascular Event with Houston Methodist Hospital and AbioMed

  • $
  • Home
  • $
  • Company Updates
  • $
  • FundamentalVR Announces Upcoming Endovascular Event with Houston Methodist Hospital and AbioMed
August 2023 - FundamentalVR is pleased to announce its upcoming Endovascular Event: An Hour With the Experts, which will be featured as part of the Houston Methodist Institute for Robotics, Imaging, and Navigation 3rd annual virtual Symposium on October 3rd, 2023.
Published August 16, 2023

BOSTON, MA – August 16, 2023FundamentalVR, a global leader in immersive surgical training, is pleased to announce its upcoming Endovascular Event: An Hour With the Experts, which will be featured as part of the Houston Methodist Institute for Robotics, Imaging, and Navigation 3rd annual virtual Symposium on October 3rd, 2023. Streamed live from the DeBakey CV Education studios, the event will explore the role of immersive virtual reality (VR) training in advancing endovascular procedures and patient outcomes. The panel will feature conversations with distinguished industry luminaries, Molly Newsom, Associate Director, Innovative Educational Solutions at AbioMed, and Dr. Alan B. Lumsden, MD, Chair, Department of Cardiovascular Surgery at Houston Methodist, who will engage in thought-provoking discussions on the groundbreaking applications of VR in endovascular training.

As a trailblazer in the field, FundamentalVR was founded to transform traditional surgical training methods through VR, to lower surgical risks and improve patient outcomes globally. The Endovascular Event underscores the company’s commitment to further solidify its pivotal role in the field and its unwavering commitment to continuous growth and innovation.

The event will offer a valuable opportunity for healthcare professionals, including medical device and pharmaceutical companies, seeking to deepen their understanding of how to implement successful VR training to accelerate product roll-out and adoption for endovascular procedures. Participants will be able to engage with the experts and explore a range of vital topics, including ​​medical device and procedure workflows; the scalability of mobile training; endovascular procedures in the Cath Lab; and more. 

“Our commitment to reshaping the landscape of surgical training is unwavering. This event is a prime opportunity for us to demonstrate how our technologies and methodologies are driving positive change in the medical field. We are excited to explore these transformative topics and share insights that will undoubtedly contribute to the advancement of endovascular training.”

Richard Vincent, Co-Founder and CEO of FundamentalVR

About FundamentalVR

Global leader in immersive surgical training, FundamentalVR was founded with the mission to accelerate human capability in surgery and medicine by using virtual technologies. Created to transform traditional surgical training methods through VR, precision simulation, and a patented kinesthetic haptic system with data, artificial intelligence, and multimodal learning, FundamentalVR is advancing pre-human competence to improve patient outcomes. Its Fundamental Surgery platform allows for full rehearsal of medical and surgical procedures, and its patented HapticVRTM technology mimics the physical touch of surgical actions and accurately simulates the sensations of bone textures, muscle, and soft tissue. The platform’s unlimited multi-user capabilities and mixed modalities all work individually or together for each business case, accelerating the time in which products and procedures can be brought to market and improve patient outcomes. These industry-leading features have resulted in FundamentalVR’s platform being the only immersive training solution accredited by leading global education institutions such as the AAOS and the Royal College of Surgeons of England. For more information, please visit FundamentalVR.com

About The Speakers:

About Richard Vincent

Richard brings 20+ years of experience in building international businesses and has throughout his career sought opportunities for positive market disruption through technological application. It was this desire that led him to co-found FundamentalVR to help address an age-old problem for the medical market; how to create safe, realistic, measurable spaces to learn, train and develop skills. In his role as CEO, Richard is responsible for building a world-class team of medical, learning, and technologists who together can realize the company’s ambition of creating the world’s first global, haptically enabled, low-cost platform.

About Dr. Alan B. Lumsden, MD

Dr. Lumsden’s academic career began in 1989 at Emory University in Atlanta, Georgia where he completed his postdoctoral training and served as a Collaborative Scientist in the Division of Pathobiology and Immunology at the renowned Yerkes Primate Centre. He remained at Emory for several years, rising to the rank of Associate Professor and Chief of the Division of Vascular Surgery. In 2002, Dr. Lumsden joined the faculty at the Baylor College of Medicine in Houston, Texas as Professor and Chief of the Division of Vascular Surgery and Endovascular Therapy. He assumed his current position at Houston Methodist in 2008 where he is currently Chief Medical Officer at the Houston Methodist Institute for Technology, Innovation and Education (MITIESM) and Director of the DeBakey Heart & Vascular Center.

Dr. Lumsden has developed an international reputation as a leader in the field of endovascular surgery. He has clinical and research expertise in stent graft treatment of thoracic and abdominal aortic aneurysms, stenting and endarterectomy in carotid arterial disease, renovascular hypertension, aortoiliac occlusive disease, mesenteric vascular and minimally invasive therapy in venous disease. Dr. Lumsden also conducts FDA-mandated training for surgeons nationwide in a carotid stenting simulator housed at the Houston Methodist DeBakey Heart and Vascular Center.

About Molly Newsom

Molly has spent the past 25 years in the cardiology space. She began her career as a cardiovascular radiographer in the cardiac cath lab and interventional radiology before joining Abiomed in 2009 as a Clinical Consultant. Initially she trained physicians and staff on the use of the Impella as well as supported patients in cardiogenic shock and undergoing high-risk PCI procedures. Molly has always had a passion for training and more recently, has primarily focused on developing training programs and processes. 

Further reading…

Stay informed

Subscribe to our newsletter for monthly updates